bio

Tatiana Chartomatsidou | BSc, MSc

Clinical Embryologist

BIOGRAPHY

Tatiana received her Bachelor of Science degree in Biology from Aristotle University of Thessaloniki in 2013. Her studies were targeted in the field of Molecular Biology, Genetics and Biotechnology. Her diplomatic research focused in the evaluation of the genotoxic and antigenotoxic effects of natural agents using both in vitro and in vivo techniques.


In 2012 she completed her internship in “Theageneio” Hospital where, she was trained in molecular diagnostics in viral infections of HPV.


During the next two years she completed her Master degree in Aristotle University of Thessaloniki, attending the Postgraduate Study Program “Applied Genetics and Biotechnology”, where she was involved in the challenging field of Molecular Biology and Cytogenetic. In her thesis, she performed mitochondrial DNA and chromosome analysis, using molecular and cytogenetic techniques, along with the use of bioinformatic tools.


During 2016-2017, she also participated in the Educational Study Program in “Human Reproduction” at Kapodistrian University of Athens.


Tatiana joined our team in 2017, as our younger trainee embryologist.


 

Scientific publications , presentations, papers

  1. Papanikolaou E, Timotheou E, Tatsi P, Chartomatsidou T, Asouchidou I, Grynberg M, Vlachou C, Katsoula E, Najdecki R. Long-Antagonist protocol versus Classical-day-6 Antagonist. Single luteal use of long-acting GnRH-antagonist Degarelix can efficiently downregulate LH during ovarian stimulation for IVF achieving comparable pregnancy outcome. ESHRE Annual Meeting, Vienna 2019 (oral presentation)
  2. Najdecki R, Choulaira F, Timotheou E, Tatsi P, Chartomatsidou T, Asouchidou E, Pakaki F, Bouchlariotou S, Humaidan P, Papanikolaou E. Single follicular degarelix, a new long acting GnRH-antagonist for LH surge suppression during ovarian stimulation in oocyte donors. A randomised controlled trial. ESHRE Annual Meeting, Vienna 2019 (oral presentation)
  3. Timotheou E, Chartomatsidou T, Tatsi P, Katsoula E, Vlachou C, Stamataki S, Asouchidou I, Zafeiratis O, Najdecki R, Papanikolaou E. Cumulative Live Birth Rates (CLBR) in patients following Freeze-all policy are higher compared to patients who undergo fresh embryotransfer (ET) followed by frozen-thawed embryotransfers. ESHRE Annual Meeting, Vienna 2019 (poster presentation)
  4. Papanikolaou E, Chartomatsidou T, Timotheou E, Tatsi P, Katsoula E, Vlachou C, Asouchidou I, Zafeiratis O, Najdecki R. In Freeze-All Strategy, Cumulative Live Birth Rate (CLBR) Is Increasing According to the Number of Blastocysts Formed in Women <40 Undergoing Intracytoplasmic Sperm Injection (ICSI). Front Endocrinol. 2019; 10 (427) https://www.frontiersin.org/articles/10.3389/fendo.2019.00427/full
  5. Papanikolaou EG, Yarali H, Timotheou E, Tatsi, P, Chartomatsidou T, Grynberg M, Zafeiratis O, Vlachou C, Tournaye H  and Najdecki R. Long-Antagonist protocol; single luteal use of long-acting GnRH-antagonist Degarelix can efficiently downregulate LH during ovarian stimulation for IVF. A proof of concept. ESHRE Annual Meeting, Barcelona 2018 (Award nominee)
  6. Chartomatsidou T, Timotheou E, Tatsi P, Katsoula E, Zafeiratis O, Najdecki R, Papanikolaou E. In Freeze-all strategy Cumulative Live Birth Rate (CLBR) is increasing according to the number of blastocysts formed in women <40 undergoing Intracytoplasmic Sperm Injection (ICSI). ESHRE Annual Meeting, Barcelona 2018
  7. Papanikolaou E, Timotheou E, Tatsi P, Chartomatsidou T, Najdecki R. Long-Antagonist protocol; luteal administration of a single dose of Degarelix (long-acting GnRH-antagonist) for controlled ovarian stimulation. A new protocol for IVF. ASRM Scientific Congress & Expo, Denver, Colorado, 2018